Abstract: Indoloquinoxalin was fused with 2,3 diphenyl quinoxaline by a methylene bridge which was then allowed for acetylation. The acetylated product was made to react with different aromatic aldehydes to give chalcones. Chalcones refluxed with substituted acid hydrazides to afford different indoloquinoxaline pyrazolines. The structure of chalcones and indoloquinoxaline pyrazolines were confirmed by M.P, TLC and spectral data. All the synthesized compounds were screened for their antioxidant, antiinflammatory and antihistamic activities.
Introduction
Quinoxaline derivatives have been reported to possess a wide variety of biological activities [1] [2] [3] . Notable among these are antioxidant, anti-inflammatory antimicrobial, anticancer and antihistamic activities. Drugs having pyrazoline ring system [4] [5] [6] are well known for their anti-inflammatory, antioxidant, antihistamic, antimicrobial, antidepressant, hypoglycemic, hypotensive, anticarcinogenic activities etc. In view of the above facts, we report here in the synthesis of some indoloquinaxoline pyrazoline derivatives by condensing indoloquinoxaline chalcones with different aromatic acid hydrazides. All the synthesized compounds (IQVI 1-IQVI 15) were screened for their antioxidant, anti-inflammatory and antihistamic activities. The structure of chalcones and indoloqunoxaline pyrazolines were confirmed by M.P, TLC, Spectral data (Table 1 & 2) .
Experimental
The melting point of the compounds was determined on a Thoshniwal electric melting point apparatus and the values were uncorrected. I.R spectra of the compounds were recorded on a Thermo Nicolet Nexus 670-FTIR, IICT, Hyderabad using KBr disc method. 1 H NMR spectra were recorded on Avance-300, IICT, Hyderabad using CDCl 3 as solvent. Mass spectra were recorded on GCMS-Auto tuning-EI at IICT, Hyderabad. All the solvents used were of analytical grade. 
General procedure for Synthesis of
and chloro acetone (0.01 M) were taken into 250 mL round bottom flask. 150 mL of dry acetone and 30 g of anhydrous potassium carbonate was added to it and the reaction mixture was refluxed for 6 h at 75 o C. Filtrate obtained was concentrated under vacuum. The purity of the compound (IQ IV) was checked by TLC and melting point.
General procedure for Synthesis of 1-(2-((2, 3-diphenylquinaxaline-6-yl) methyl)-6H-indolo[2, 3-b]quinaxaline-6-yl)but-3-en-2-one 9
A solution of NaOH/KOH (8 mL, 10% in water) was added drop wise to a well stirred solution of (0.01
quinaxaline-6-yl) propan-2one (IQ IV) and 0.01 M appropriate p-aryl aldehyde in 20 mL ethanol at cold temperature. The reaction mixture was stirred for 24 h. at room temperature. Then diluted with ice water and acidified with Con.HCl. The product was filtered and recrystallized with aqueous ethanol. The purity of the compounds (IQV 1-IQV 5) was checked by TLC and melting point.
General procedure for Synthesis of 4,5-dihydro-5-phenyl-3-((2-((2,3-
e., Chalcones) (0.01 M) and aromatic acid hydrazide (0.02 M) were taken in 20 mL glacial acetic acid and refluxed for 10 h above 130 o C. The reaction mixture was concentrated and poured in 300 mL of ice-cold water and recrystallized with aq.ethanol. The purity of the compounds (IQVI 1-IQVI 15) was checked by TLC and melting point. The physical data are shown in Table 1 .
Pharmacological evaluation
Antioxidant activity 11 
DPPH method
All drugs have been diluted in 95% ethanol to get 1000 µg, 500 µg, 250 µg, 100 µg, 50 µg and 25 µg, 10 µg/mL concentrations. DPPH solution (2 µ.mol) has been prepared by 95% ethanol. Then 0.5 mL of drug solution and 0.5 mL of DPPH solution (freshly prepared) were added. 0.5 mL of DPPH solution and 0.5 mL of ethanol were used as control. Reaction mixture was allowed for 20 min. UV absorbance was measured at 517 nm. The percentage of scavenging has been calculated by the equation given below. Ascorbic acid was used as standard drug (Table 3) . 
Anti-inflammatory activity

Carrageenan induced rat hind paw edema method
The method of Winter et al. 12 was used with slight modification. The apparatus used for the measurement of rat paw volume was phlethismograph. The animals were divided into eight groups of six animals each. One group served as a standard (Ibuprofen) and another group served as control (1% CMC) and rest of the groups were used for the test drugs. Food was withdrawn overnight with adequate water before the experiment. The drugs were given orally. After 1 h, a sub plantar injection of 0.05 mL of 1% carrageenan was administered. The volume of the injected paw was measured with a plethysmograph immediately. The paw volume was again measured after 3 h. The average paw volume in a group of drug treated rats was compared with that of a group with vehicle (control group) and the percentage inhibition of oedema was calculated using the formula (Table 4) .
% Inhibition = (1-Vt / Vc) x 100 Vt = Mean volume of the test drug, Vc = Mean volume of the control. Anti-histaminic activity 13 
Histamine chamber method
In this method thirty two healthy adult guinea pigs of either sex divided into 8 group of 2 animals each weighing around 400 g, fasted overnight, were kept in histamine chamber and exposed to histamine aerosol (0.5% aqueous solution of histamine acid phosphate in a Nebulizer) until they collapse. Those that collapse within 2 minutes were revived with fresh air and used for this test. Twelve hours later, the animals were given an oral dose of test compound suspended in 1% acacia solution and after 1 h for absorption, the guinea pigs were again exposed to the same concentration of histamine aerosol. Those that do not collapse within 6 minutes are deemed protected. Percentage protection has been measured by calculating the time of onset of convulsions (Table 5) .
Results and Discussion
All the compounds were synthesized through the depicted in the Scheme 1 and confirmed by IR, 1 H NMR, mass spectroscopy. Indoquinaxoline and diphenyl quinaxoline and both these quinoxalines were connected with methylene bridge, which is then allowed for acetylation. The acetylated product (IQ IV) was made to react with different aromatic aldehydes to give chalcones (IQV 1-IQV 5). Chalcones refluxed with substituted acid hydrazides to afford different phenylpyrazolo indoloquinoxaline derivatives (IQVI 1-IQVI 15) . All the compounds shown significant antioxidant activity among them IQVI-3 45.45%, IQVI 5 50.9%, IQVI 8 27.12%, IQVI13 40.59%, IQVI 14 58.33% and IQVI 15 59.40% showed good free radical scavenging activity (Table 3 ). In the anti-inflammatory activity, compounds IQVI 13 77.50% IQVI 14 81.25 and IQVI 15 90.00% showed good inhibition of edema volume (Table 4) and compounds IQVI 3 90.4%, IQVI 4 90.7% IQVI 8 90.5% and IQVI 10 90.9% showed good % protection of antihistamic activity (Table 5) . 
Conclusion
Indoquinoxaline and diphenylquinoxaline both these quinoxalines were connected with methylene bridge, which is then allowed for acetylation. The acetylated product (IQ IV) is made to react with different aromatic aldehydes to give chalcones (IQV 1-IQV 5).
Chalcones refluxed with substituted acid hydrazides to afford different phenyl pyrazolo indoloquinoxaline derivatives (IQVI 1-IQVI 15) . The synthesized compounds were checked for antioxidant, anti-inflammatory and antihistamic activity.
